Clinical trials

  • REGORAFENIB for Solid malignant tumors
  • NIPOCALIMAB for Fetal and neonatal alloimmune thrombocytopenia (FNAIT)
  • OCRELIZUMAB for Relapsing-remitting multiple sclerosis
  • Platelet concentrate for Diabetic foot ulcer | Peripheral arterial disease | Diabetes mellitus
  • DANICOPAN for Paroxysmal nocturnal haemoglobinuria
  • PROPRANOLOL for Post-traumatic stress disorder
  • crizotinib for Neuroblastoma | Rhabdomyosarcoma | Inflammatory myofibroblastic tumor | ALK/ROS1/MET-positive malignancies | Anaplastic large cell lymphoma
  • 18F-PSMA-1007 for Prostate cancer
  • 68GA-DPI-4452 for Clear cell renal cell carcinoma | Pancreatic ductal adenocarcinoma | Colorectal cancer | Urothelial carcinoma | Indeterminate renal mass | Head and neck cancer | Triple Negative breast cancer | Squamous non-small cell lung cancer
  • [AL[18F]F]FAPI-74 for Progressive pulmonary fibrosis | Pulmonary fibrosis
  • DOCETAXEL for Prostate cancer | Metastatic castration-resistant prostate cancer
  • CYTARABINE, DAUNORUBICIN for Acute myeloid leukaemia (AML) | AML with myelodysplasia-related changes (AML-MRC) | Therapy-related acute myeloid leukaemia